The global autoimmune disease diagnostics market size was valued at USD 5.39 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2030. Unceasing growth in new cases of autoimmune disease, increasing focus of professionals and practitioner... Read More »
September 2024The global disruptive behavior disorder treatment market size was valued at USD 1.42 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030. This growth is attributed to increased awareness, enhanced diagnostic abilities, and a changing... Read More »
September 2024The Europe bladder cancer diagnostics market size was estimated at USD 786.10 million in 2023 and is expected to grow at a CAGR of 8.38% from 2024 to 2030. The market growth can be attributed to the ongoing advancements in noninvasive diagnostics and a shift toward a precision-based appr... Read More »
September 2024The global malaria diagnostics market size was estimated at USD 759.1 million in 2023 and is projected to grow at a CAGR of 2.6% % from 2024 to 2030. The market is being propelled by an increasing need for malaria diagnostics and the advent of innovative diagnostic methods. ... Read More »
September 2024The global liver disease diagnostics market size was valued at USD 35.37 billion in 2023 and is anticipated to grow at a CAGR of 6.61% from 2024 to 2030. A significant driver expected to boost the liver disease diagnostics market is the growing prevalence of both acute and chro... Read More »
September 2024The Asia Pacific point of care diagnostics market size was valued at USD 9.31 billion in 2023 and is projected to grow at a CAGR of 8.4% from 2024 to 2030. Asia Pacific witnessed significant growth in the point of care diagnostics market due to the rising healthcare expenditure, increase... Read More »
September 2024The global employer and workplace drug testing market size was estimated at USD 5.90 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030. This is attributed to a combination of regulatory requirements, workplace safety concerns, and an increasing societal emphasi... Read More »
September 2024The China Alzheimer’s disease diagnostics market size was estimated at USD 287.76 million in 2023 and is expected to grow at a CAGR of 12.1% from 2024 to 2030. The increasing prevalence of Alzheimer’s disease (AD), growing use of biomarkers in disease diagnostics, growing ado... Read More »
September 2024The Latin America PoC infectious disease testing market size was estimated at USD 886.6 million in 2023 and is anticipated to grow at a CAGR of 2.7% from 2024 to 2030. This growth is driven by the high prevalence of infectious diseases, advancements in diagnostic technologies, supportive... Read More »
September 2024The Asia Pacific point of care TB and drug-resistant TB testing market size was estimated at USD 2.53 billion in 2023 and is anticipated to grow at a CAGR of 6.6% from 2024 to 2030. This growth is driven by the region's high TB burden, technological advancements in diagnostics, supportiv... Read More »
September 2024The Europe point of care TB and drug-resistant TB testing market size was estimated at USD 102.6 million in 2023 and is expected to grow at a CAGR of 5.7% from 2024 to 2030. The high prevalence of TB and DR-TB in Europe, coupled with increasing governmental and organizational initiatives... Read More »
September 2024The China lung cancer screening market size was estimated at USD 505.17 million in 2023 and is projected to grow at CAGR of 11.09% from 2024 to 2030. The growth of the market is driven by several key factors, including the high prevalence of lung cancer, advances in screening technology,... Read More »
September 2024The U.S. employer and workplace drug testing market size was estimated at USD 2.47 billion in 2023 and is projected to grow at a CAGR of 5.1% from 2024 to 2030. The market growth is driven by a combination of regulatory mandates, workplace safety concerns, and the growing societal focus ... Read More »
September 2024The global pediatric cancer biomarkers market size was estimated at USD 815.81 million in 2023 and is projected to grow at a CAGR of 8.5% from 2024 to 2030, due to the increasing prevalence of pediatric cancers and advancements in molecular biology. According to the National Cancer Insti... Read More »
September 2024The global cancer biopsy market size was valued at USD 30.05 billion in 2023 and is projected to grow at a CAGR of 8.11% from 2024 to 2030. The growth of the market is attributed to the increasing prevalence of cancer, which is propelling the need for innovative diagnostics to provide ea... Read More »
September 2024The global pediatric allergy diagnostics market size was estimated at USD 2.44 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024 to 2030. Environmental factors such as increased pollution, changing lifestyles, and urbanization have contributed to a higher incidence of... Read More »
September 2024The global primary care PoC diagnostics market size was valued at USD 21.44 billion in 2023 and is projected to grow at a CAGR of 2.8% from 2024 to 2030. The market growth can be attributed to the factors such as rising prevalence of chronic diseases, the rising number of point-of-care d... Read More »
August 2024The global structural heart imaging market size was valued at USD 8.84 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The major factors driving the growth of the structural heart imaging market are the increasing prevalence of various congenital, increase i... Read More »
August 2024The global cannabis testing services market size was estimated at USD 1.80 billion in 2023 and is projected to grow at a CAGR of 17.21% from 2024 to 2030. Factors such as increasing legalization of cannabis for recreational and medical purposes, rising use of cannabis in medicinal applic... Read More »
August 2024The global blood-based biomarker for sports medicine market was estimated at USD 665.4 million in 2023 and is projected to grow at a CAGR of 6.7% from 2024 to 2030.The market is driven by increased focus on personalized health, advancements in biomarker technology, and growing demand for... Read More »
August 2024